Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DINA IOFFE

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1154856417
CMS profile
11307276
Location
PHILADELPHIA, PA

General Payments · PY2021–2024

$2,704.00

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,632.63

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,749.58 12
Travel and Lodging $883.05 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BOSTON SCIENTIFIC CORPORATION $2,073.66 6
Acerta Pharma LLC $328.20 6
Intera Oncology, Inc $107.25 1
EISAI INC. $77.03 1
Genentech USA, Inc. $46.49 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $24.08 1
PY2023 $47.29 2
PY2024 $2,632.63 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $100.24 03/21/2024 Food and Beverage Undisputed 01/23/2026 1104197795 CMS
AstraZeneca Pharmaceuticals LP $34.37 04/15/2024 Food and Beverage Undisputed 01/23/2026 1104308066 CMS
AstraZeneca Pharmaceuticals LP $135.00 06/01/2024 Food and Beverage Undisputed 01/23/2026 1104554576 CMS
AstraZeneca Pharmaceuticals LP $22.49 07/15/2024 Food and Beverage Undisputed 01/23/2026 1105638438 CMS
AstraZeneca Pharmaceuticals LP $27.20 07/17/2024 Food and Beverage Undisputed 01/23/2026 1105418860 CMS
AstraZeneca Pharmaceuticals LP $8.90 07/20/2024 Food and Beverage Undisputed 01/23/2026 1104262189 CMS
Boston Scientific Corporation $191.95 11/07/2024 Food and Beverage Undisputed 01/23/2026 1092325359 CMS
Boston Scientific Corporation $281.95 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1092325361 CMS
Boston Scientific Corporation $300.55 11/07/2024 Travel and Lodging Undisputed 01/23/2026 1092325363 CMS
Boston Scientific Corporation $601.80 11/08/2024 Food and Beverage Undisputed 01/23/2026 1092325355 CMS
Boston Scientific Corporation $300.55 11/08/2024 Travel and Lodging Undisputed 01/23/2026 1092325365 CMS
Boston Scientific Corporation $396.86 11/09/2024 Food and Beverage Undisputed 01/23/2026 1092325367 CMS
Eisai Inc. $77.03 05/23/2024 Food and Beverage Undisputed 01/23/2026 1110742029 CMS
Genentech USA, Inc. $46.49 06/02/2024 Food and Beverage Undisputed 01/23/2026 1133002240 CMS
Intera Oncology, Inc $107.25 02/27/2024 Food and Beverage Undisputed 01/23/2026 1089554070 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.